Current and future therapy in haemochromatosis and Wilson’s disease

Author： Murray Karen F   Lam Dickson   Kowdley Kris V  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.12, 2003-12, pp. : 2239-2251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapeutic approaches to the treatment of Wilson’s disease

By Brewer George J  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 3, 2006-02 ,pp. : 317-324

Informa Healthcare

Access to resources Recommend Favorite

Zinc acetate for the treatment of Wilson’s disease

By Brewer George J  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 9, 2001-09 ,pp. : 1473-1477

Informa Healthcare

Access to resources Recommend Favorite

Neurologically Presenting Wilson’s Disease: Epidemiology, Pathophysiology and Treatment

By George J. Brewer  

CNS Drugs, Vol. 19, Iss. 3, 2005-01 ,pp. : 185-192

Adis International

Access to resources Recommend Favorite

Perspectives for Gene Therapy of Wilson Disease

By  

Current Gene Therapy, Vol. 7, Iss. 3, 2007-06 ,pp. : 217-220

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy for Parkinson's Disease: Current Status and Future Potential

By Segovia J.  

American Journal of PharmacoGenomics, Vol. 2, Iss. 2, 2002-01 ,pp. : 135-146

Adis International

Access to resources Recommend Favorite